AI assistant
FIREFLY NEUROSCIENCE, INC. — Director's Dealing 2025
Mar 19, 2025
34703_dirs_2025-03-19_9952ce04-b081-4e30-88da-6743e17bc607.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FIREFLY NEUROSCIENCE, INC. (AIFF)
CIK: 0000803578
Period of Report: 2024-08-12
Reporting Person: Issachar Gil (Chief Technology Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 33480 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $721.1500 | 2023-08-13 | Common Stock (13) | Direct | |
| Employee Stock Option (Right to Buy) | $72.1200 | 2025-10-14 | Common Stock (222) | Direct | |
| Employee Stock Option (Right to Buy) | $72.1200 | 2026-04-01 | Common Stock (77) | Direct | |
| Employee Stock Option (Right to Buy) | $72.1200 | 2026-06-21 | Common Stock (1308) | Direct | |
| Employee Stock Option (Right to Buy) | $28.8200 | 2027-11-17 | Common Stock (2920) | Direct | |
| Employee Stock Option (Right to Buy) | $5.1800 | 2028-07-08 | Common Stock (75418) | Direct |
Footnotes
F1: Gil Issachar was granted an option to purchase 13 shares of common stock ("Option Shares") at an exercisable price of $721.15 per share on August 13, 2018.
F2: Gil Issachar was granted an option to purchase 222 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on October 14, 2020.
F3: Gil Issachar was granted an option to purchase 77 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on April 1, 2021.
F4: Gil Issachar was granted an option to purchase 1,308 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on June 21, 2021.
F5: Gil Issachar was granted an option to purchase 2,920 shares of common stock ("Option Shares") at an exercisable price of $28.82 per share on November 17, 2022.
F6: Gil Issachar was granted an option to purchase 75,418 shares of common stock ("Option Shares") subject a vesting schedule, in which the 75,418 Option Shares shall be vested in equal installment at the end of each calendar month for 36 months began on the date of grant on July 8, 2023.